Autori: Zimran Ari
| Naslov | Long-term efficacy and safety results of taliglucerase alfa through 5 years in adult treatment-naive patients with Gaucher disease (Article) |
| Autori | Zimran Ari Duran Gloria Giraldo Pilar Rosenbaum Hanna Giona Fiorina Petakov Milan S Terreros Munoz Eduardo Eduardo Solorio-Meza Sergio Cooper Peter A Varughese Sheeba Alon Sari Chertkoff Raul |
| Info | BLOOD CELLS MOLECULES AND DISEASES, (2019), vol. 78 br. , str. 14-21 |
| Projekat | Protalix BioTherapeutics; Pfizer |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Long-term safety and efficacy of taliglucerase alfa in pediatric Gaucher disease patients who were treatment-naive or previously treated with imiglucerase (Article) |
| Autori | Zimran Ari Gonzalez-Rodriguez Derlis Emilio Abrahamov Aya Cooper Peter A Varughese Sheeba Giraldo Pilar Petakov Milan S Tan Ee Shien Chertkoff Raul |
| Info | BLOOD CELLS MOLECULES AND DISEASES, (2018), vol. 68 br. , str. 163-172 |
| Projekat | Protalix BioTherapeutics; Pfizer |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Enzyme replacement therapy with taliglucerase alfa: 36-month safety and efficacy results in adult patients with Gaucher disease previously treated with imiglucerase (Article) |
| Autori | Pastores Gregory M Shankar Suma P Petakov Milan S Giraldo Pilar Rosenbaum Hanna Amato Dominick J Szer Jeffrey Chertkoff Raul Brill-Almon Einat Zimran Ari |
| Info | AMERICAN JOURNAL OF HEMATOLOGY, (2016), vol. 91 br. 7, str. 661-665 |
| Projekat | Protalix BioTherapeutics; Pfizer |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Long-term efficacy and safety results of taliglucerase alfa up to 36 months in adult treatment-naive patients with Gaucher disease (Article) |
| Autori | Zimran Ari Duran Gloria Mehta Atul Giraldo Pilar Rosenbaum Hanna Giona Fiorina Amato Dominick J Petakov Milan S Munoz Eduardo Terreros Solorio-Meza Sergio Eduardo Cooper Peter A Varughese Sheeba Chertkoff Raul Brill-Almon Einat |
| Info | AMERICAN JOURNAL OF HEMATOLOGY, (2016), vol. 91 br. 7, str. 656-660 |
| Projekat | Protalix BioTherapeutics; Pfizer |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with imiglucerase (Article) |
| Autori | Pastores Gregory M Petakov Milan S Giraldo Pilar Rosenbaum Hanna Szer Jeffrey Deegan Patrick B Amato Dominick J Mengel Eugen Tan Ee Shien Chertkoff Raul Brill-Almon Einat Zimran Ari |
| Info | BLOOD CELLS MOLECULES AND DISEASES, (2014), vol. 53 br. 4, str. 253-260 |
| Projekat | Protalix BioTherapeutics; Pfizer |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Pivotal trial with plant cell-expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher disease (Article) |
| Autori | Zimran Ari ... Petakov Milan S ... (broj koautora 21) |
| Info | BLOOD, (2011), vol. 118 br. 22, str. 5767-5773 |
| Projekat | Protalix Biotherapeutics; Chief Scientist Office of the Israeli Ministry of Industry |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Significant and continuous improvement in bone mineral density among type 1 Gaucher disease patients treated with velaglucerase alfa: 69-month experience, including dose reduction (Article) |
| Autori | Elstein Deborah Foldes Joseph A Zahrieh David Cohn Gabriel M Djordjevic Maja S Brutaru Costin Zimran Ari |
| Info | BLOOD CELLS MOLECULES AND DISEASES, (2011), vol. 47 br. 1, str. 56-61 |
| Projekat | Shire Human Genetic Therapies ; Protalix Therapeutics ; Genzyme Corporation |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
